Financhill
Back

Viking Therapeutics Stock Predictions

Viking Therapeutics Stock Forecast

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 138.9% based on the past 8 years of stock performance.
  • Viking Therapeutics has risen higher in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Viking Therapeutics Stock Undervalued?
    The current Viking Therapeutics [VKTX] share price is $66.95. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Viking Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Viking Therapeutics has on average historically risen by 138.9% based on the past 8 years of stock performance.

Viking Therapeutics Stock Rating

Buy
53
Viking Therapeutics (VKTX) is a Buy

Is Viking Therapeutics overpriced?

  • Viking Therapeutics has risen higher in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Viking Therapeutics Stock Price History

Is VKTX stock going to rise?

  • The current trend is moderately bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
stock
Website:
vikingtherapeutics.com

52-Week Data

52-Week High:
99.41
52-Week Low:
8.28

Prediction Charts

Market Cap:
6.73B
Price in USD:
66.95
Volume:
2.12M
Beta:
1.50

Technical Analysis

SMA50:
61.14
SMA100:
39.83
SMA200:
26.42
52-Wk Change:
257.07%

Stock Predictions

  • Is Viking Therapeutics stock public?
    Yes, Viking Therapeutics is a publicly traded company.
  • What is the Viking Therapeutics stock quote today?
    The Viking Therapeutics stock price is 66.95 USD today.
  • How to buy Viking Therapeutics stock online?
    You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-26 77.51 80.83 89.10 76.92
Mar-27 82.08 83.34 85.20 78.65
Mar-28 83.50 81.93 84.70 80.50
Apr-1 81.97 79.55 82.00 77.25
Apr-2 77.00 77.35 78.46 73.40
Apr-3 77.00 78.43 80.74 76.00
Apr-4 79.05 73.68 80.10 73.32
Apr-5 73.69 76.41 77.77 72.41
Apr-8 75.43 75.84 76.81 74.03
Apr-9 75.22 72.83 76.18 71.74
Apr-10 70.50 71.63 71.84 68.30
Apr-11 70.94 70.87 71.73 70.39
Apr-12 70.00 68.62 70.81 68.42
Apr-15 68.51 66.95 70.00 66.25

Viking Therapeutics Earnings

Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Viking Therapeutics Forecast Revenue Growth

Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.13 per share, and a decrease next year of $0.47 per share.

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.